Related references
Note: Only part of the references are listed.Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
Martina Broecker-Preuss et al.
BMC CANCER (2015)
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression
Devora Champa et al.
ENDOCRINE-RELATED CANCER (2014)
The multiple facets of drug resistance: one history, different approaches
Evandro Luis Niero et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes
F. Basit et al.
CELL DEATH AND DIFFERENTIATION (2013)
GX15-070 (Obatoclax) Induces Apoptosis and Inhibits Cathepsin D- and L-Mediated Autophagosomal Lysis in Antiestrogen-Resistant Breast Cancer Cells
Jessica L. Schwartz-Roberts et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Autophagy in Human Health and Disease REPLY
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mechanical model of blebbing in nuclear lamin meshworks
Chloe M. Funkhouser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
MECHANISMS OF DISEASE Autophagy in Human Health and Disease
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
New treatment modalities in advanced thyroid cancer
E. Kapiteijn et al.
ANNALS OF ONCOLOGY (2012)
Approach to the patient with advanced differentiated thyroid cancer
M. Schlumberger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review
Naval Bajwa et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
J. S. Long et al.
ONCOGENE (2012)
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas
Elizabeth A. Brem et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
Tina C. Albershardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells
Rory L. Smoot et al.
CANCER RESEARCH (2010)
The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy
Yue Wei et al.
CLINICAL CANCER RESEARCH (2010)
Cytotoxic Chemotherapy for Differentiated Thyroid Carcinoma
S. I. Sherman
CLINICAL ONCOLOGY (2010)
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
Laura Bonapace et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
N. Heidari et al.
CELL DEATH & DISEASE (2010)
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK
F. McCoy et al.
CELL DEATH & DISEASE (2010)
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel et al.
APOPTOSIS (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
Different forms of cell death induced by putative BCL2 inhibitors
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2009)
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Robert C. Smallridge et al.
ENDOCRINE-RELATED CANCER (2009)
Non-Peptidic Small Molecule Inhibitors Against Bcl-2 for Cancer Therapy
Asfar S. Azmi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers
Steven I. Sherman
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains
Gregory Bellot et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
Cytogenetical observations in five human anaplastic thyroid carcinomas
JOACHIM MARK et al.
HEREDITAS (2008)
BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis
Justin L. Mott et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells
P. Perez-Galan et al.
LEUKEMIA (2008)
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Jerry E. Chipuk et al.
TRENDS IN CELL BIOLOGY (2008)
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Autophagy is required for necrotic cell death in Caenorhabditis elegans
C. Samara et al.
CELL DEATH AND DIFFERENTIATION (2008)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Autophagosome formation: Core machinery and adaptations
Zhiping Xie et al.
NATURE CELL BIOLOGY (2007)
New trends in the treatment of undifferentiated carcinomas of the thyroid
Paolo Miccoli et al.
LANGENBECKS ARCHIVES OF SURGERY (2007)
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel et al.
BLOOD (2007)
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Patricia Perez-Galan et al.
BLOOD (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
New therapeutic approaches for metastatic thyroid carcinoma
Eric Baudin et al.
LANCET ONCOLOGY (2007)
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells
Clara Campas et al.
EXPERIMENTAL HEMATOLOGY (2006)
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins
D. Zhai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans
M Artal-Sanz et al.
JOURNAL OF CELL BIOLOGY (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
Anaplastic thyroid carcinoma - Treatment outcome and prognostic factors
E Kebebew et al.
CANCER (2005)
Development by self-digestion: Molecular mechanisms and biological functions of autophagy
B Levine et al.
DEVELOPMENTAL CELL (2004)
Autophagosome formation in mammalian cells
N Mizushima et al.
CELL STRUCTURE AND FUNCTION (2002)
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
S Fulda et al.
ONCOGENE (2002)
Organelle-specific initiation of cell death pathways
KF Ferri et al.
NATURE CELL BIOLOGY (2001)
Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation
A Stepczynska et al.
ONCOGENE (2001)